Public Divided On Trump Health Agenda, Strong Support For Price Transparency

When asked about a variety of health care proposals, including those put forth by Republican and Democratic lawmakers, about 6 in 10 said boosting price transparency rules to ensure that health care prices are available to patients should be a top priority.

Read More

Medicare Targets 15 More Drugs For Price Negotiations — Including Ozempic

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the federal government and the pharmaceuticals industry are about to go head-to-head once again. The Centers for Medicare and Medicaid Services negotiated prices for a first ...

Read More

Top Three Insurers Reaped $7.3 Billion Through Their Drug Middlemen’s Markups, FTC Says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" prescription price hikes of 1,000% or more.

Read More

Workplace Life Insurance Sales Forecast Looks Cloudy

U.S. life insurance benefits sales might grow a little this year, or they might not. Analysts at LIMRA are predicting, cautiously, that total workplace life sales could increase 3% over the next 12 months, to about $4.5 billion, after rising 3.3% in 2024. The unemployment rate is still low. Typical employers still say they want to keep ...

Read More

Justice Department Sues Walgreens Over Alleged Unlawful Prescription Practices

Walgreens Boots Alliance (WBA, Financials) saw its stock decline on Friday following the announcement of a U.S. Department of Justice lawsuit accusing the company of knowingly filling millions of unlawful prescriptions for controlled substances. Shares closed at $12.52, down 3.17%, and extended losses in after-hours trading, falling an additional 5.03% to $11.89. Alleging that Walgreens ...

Read More

Employer Group Sues To Stop Biden Rules That ‘Overstep’ Existing Mental Health Parity Law

The ERISA Industry Committee sues to stop new Biden administration mental health regulations issued in 2024, saying they are “arbitrary and capricious” and employers cannot certify compliance “due to vague, undefined terms."

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square